Health, Fitness, Beauty and Skin Care

BECOME A LYFT DRIVER

 
View our
NEWSLETTER ARCHIVE
Email Marketing by Constant Contact®

 

 


Welcome to our website. 

"Legendary financial editor" Bob Flaherty rides again with his son Brian by his side. Flaherty is emphasizing over looked bargains of any size, including promising small cap and micro cap ventures to feel useful again. The decades have taught that happiness is a by product from serving others, and we will do our best to serve you. 

Please fill out the form and opt-in. As a subscriber you will receive our Flaherty Financial News and Flaherty Special Situation all electronic newsletters with an opt-in opt-out feature.  

Subscribe To Our Online Newsletters And Get Your Own Issues Directly In Your Email 

JOIN NOW

We are a digital content originator and electronic publisher of digital content. We cover publicly-traded companies & financial community events. We do news stories with hyperlinks to articles, company profiles and corporate videos. 

Real Financial Journalism That You Do Not See Everyday. The news stories we create ourselves will aim for objectivity, include risks and put our readers first. We will try to disclose our inevitable conflicts of interest in our disclaimers.  Because the small and mid-cap niches are neglected, we may be the only one writing about certain companies at any particular time. Stories about some subjects you will not find anywhere else. We try to search for overlooked quality companies and often succeed. 

We are a content-driven news organization, not a design-driven one. We are people with high standards and morals, and we expect the same from the people who choose to do business and interact with us.

Profiles? Yes, we specialize in writing stories and doing research on under-followed companies with upside potential. We know how to make companies come alive in words the ordinary investor can understand.   

Special Situations? Judged by two independent  outside ranking services, The Hulbert Financial Digest and Select Information Exchange, Editor Bob Flaherty has had one of the best long-term performances among all investment advisory newsletters. Because we miss the challenge of competition, we are making  new picks again.   

HOW OUTSIDE SERVICES HAVE RANKED OUR PERFORMANCE. Bob Flaherty has built an enviable reputation as an early –bird stock picker who again and again uncovers overlooked special situation bargains often before TV’s talking heads or Wall Street’s big financial firms even know of their existence. His track record as measured by The Hulbert Financial Digest and Select Information Exchange is one few other financial newsletter writers have matched. Besides being editor of Equities magazine, Flaherty was editor of Equities Special Situations for 25 years. Bob was ranked No.1 for 14 consecutive months in Long Term Portfolio Gains among all Advisory Services measured by Select Information Exchange.  

In a period  after the above SIE streak The Hulbert Financial Digest ranked Equities Special Situations #1 among any financial newsletter and #4 in the U.S. for stock performance. In several years Bob was first in his small cap category, according to The Hulbert Financial Digest, gaining an average of 1.7% in 2002, 76.5% in 2003, 16.1% in 2004 and 14.7% in 2005 versus -20.9%, 31.6%, 12.6% and 6.2% for the Wilshire 5000 Index Very few other newsletters have ever beaten their index for four consecutive years and also been up in a sharply down year like 2002. In 2006 Bob retired from Equities Magazine, which sadly slipped under the waves in stormy 2010, while his picks for 2006 were still ahead of the relevant averages. Mark Hulbert reports that over 80% of all advisory letters fail to beat the stock market over the long term. Naturally besides many big past winners, Bob has had a lot of strikeouts too as he swings for the fences, aiming for minimum gains of 50% to 100% over two years.

ONE MONTH OF CONTINUOUS POSITIVE PROMOTION CAN MAKE A DIFFERENCE AND ENHANCE AWARENESS! In fact the results were so spectacular that CEL-SCI repeated  the entire package for the sixth time!

All of our recent Flaherty Financial News and Flaherty Special Situation Newsletters have each been opened by about 3 million to 6 million online investors. Our Flaherty Special Situation #38 BUY Report on CEL-SCI (NYSE:CVM) was emailed to 90.3 million U.S., Canadian and U.K. online opt-in investor accounts in four 22.5 million investor launches each separated by one week. Over  6 million opt- in investors opened the issue. The open rate was slightly above 7%. CEL-SCI received 43,009 click-thrus and Flaherty Financial News another 53,050 click-thrus which directed investors to our home page where management strategy was featured and archived. Total click of 96,059 also set a new record.  The results from using all three countries at once were spectacular!

Take a look around to learn more about the companies we are spotlighting and our insights. We invite you to become one of our friends in the financial community. -Brian Flaherty  


At the NASDAQ Market Site ItsAboutFinance.TV host Nicole Hunt interviews Bob Flaherty over 56 years in the investment trenches. 

56 years in the investment trenches

After graduating with a Distinction in Finance and an MBA from Harvard Business School in 1961 in addition to a Magna Cum Laude in Economics from Harvard College, Flaherty started out at Forbes where he retired as a senior editor in 1981. In between Bob wrote 33 cover stories, two shy of the magazine’s all time record. He reported favorably on tiny enterprises like Xerox and FedEx which grew to become household names. Besides his first New York Deadline Club Award from The Society of Professional Journalists in 1978, he was awarded the Amos Tuck Media Award for Economic Understanding for writing the best business story in any magazine. In 1979  Flaherty was cited as outgoing president by the New York Financial Writers Association “for an outstanding performance in having returned us to a position of journalistic prominence.”

In 1984 Flaherty won the Pannell Kerr Forster Award for Excellence in Financial Journalism for a cover story "The  Secret Short Sellers." It exposed  unethical practices by  bears who destabilized companies by smearing  managements and then secretly initiating negative articles in famous media. Next  abusive  shorts  profited by  prepublication trading by increasing their positions just before publication.  Bob' articles were credited by NASD President Gordon Macklin as leading to greater disclosure in monthly short selling reporting and  other key reforms. Flaherty also wins a second Deadline Club Award from the Society of Professional Journalists for his expose of Denver penny stock scams in an article which was the first anywhere to print the nickname “Blind em and rob em “ of the notorious now defunct Blinder Robinson bucket shop.

In his salad days because of tackling the tough stories and his investigative reporting  Bob was proud be known as "Forbes Bloody Red Baron."  The late great Forbes Editor Jim Michaels wrote  Bob was "a human encyclopedia" whose past output was "awesome."

Louis Rukeyser introduced  Bob on Wall Street Week as "chief watchdog of the OTC." The National Investor Relations Institute described Flaherty as "One of the most respected financial journalists in the nation," while The Journalist and Financial Reporter included Flaherty as one of the top 96 most influential financial journalists in the country.

It's Nice To Remembered.
America needs change! Our anemic economic GNP is under 2%. The good news is some folks at Harvard Business School and many others think change could lift growth to 3% or 4%. When Bob received Steve Forbes' book " Reviving America" Bob was delighted with this hand written inscription: "To Bob, who taught me-and so many others-so much! With admiration. Steve"



Photo Album

 

Brian D. Flaherty, President and Publisher
Flaherty Financial News Newsletter Publications

Flaherty Financial News Inc.
Phone: 914-539-0688 

Brian Flaherty is a LinkedIn member. For two people to connect, one must invite the other and then the other must accept the Invitation. If the person being invited to connect is not already on LinkedIn, they'll need to join in order to accept the Invitation. 
 
Brian's Public Profile:
 
 
Join Our Newsletter Mailing List: CLICK HERE

If you would like to submit some ideas for future sponsored newsletter subject matter, we are always looking for undervalued companies that feel they need exposure to increase their stock price! Contact:

Robert J. Flaherty
Editor and Chairman
Flaherty Financial News and Flaherty Special Situations
Bob@FlahertyFinancialNews.com 
Phone: 914-831-1151

We continue to spotlight overlooked bargains and unknown quality efforts with the help of our friends in the financial community. 


 John & Bob Loved To Exchange Ideas. 

Sir John's wisdom lives on: Our spiritual and financial pathfinder Sir John Templeton ( left ) exchanging ideas with editor Bob Flaherty has "gone home" as Sir John called dying. His wisdom lives on.

Look globally in every country for bargains. Seek the least popular and best buys as measured by comparative price- earnings ratios and other value screens. Be contrarian. When nearly everyone thinks and acts quarterly, have the discipline to look out at least three years and buy what will become popular again. Take profits and invest some of your gains in new bargains. Be humble! When you make a mistake admit it as quickly as possible. Diversify by industry, investment style and especially geographic region. In this unpredictable world, no more than 25% of your equity holdings should be invested in the stocks of any one country, especially your own. Don't sit on too much cash. Remember you will never live to see a year when a U.S. dollar will buy in December as much as it did in January! Above all, be optimistic for the long run. Don't waste time worrying. In the short run try to turn every negative into a positive. Stress positive thinking! Have purpose. Everyday focus on what is positive and productive. See opportunities you would of missed. Happiness can not be found by seeking it directly. It is a by product of living a life of serving others. 


Our Treasure Chest of Ideas

Our annual “Favorites of the Famous” recommendations, started when Bob was a senior editor at Forbes Magazine, continued when he was editor of Equities Magazine and still comes out today in an annual issue of Flaherty Financial News Newsletter.The combined portfolios of our panels of wise men and women have beaten  the S&P 500 18 out of 27 efforts, including a streak of 13 consecutive times. This is one of the best long-term track records of an annual  favorite stock feature anywhere on the planet. We still get  HIGH with the help of our friends. 


Digital Copyright © 2017 Flaherty Financial News Inc. All Rights Reserved




International investors flew from Medellin over 500 miles deeper toward the Columbian border with Ecuador before transferring to military helicopters which landed guided by brush fires lit by heavily armed soldiers. Everyone exiting, including South American Gold President Ray De Motte (left) and Editor Bob Flaherty (right) , was ordered to keep moving quickly because FARC guerillas were rumored to be in the area. Next came a bumpy winding ride up around a mountain to South American Gold's (SAGD.OB) initial Santacruz Gold Project in the least explored most dangerous and therefore least picked over part of Columbia. Alas SAGD terminated the venture but the ride was fun.

 



OUR THRILLING EXPERIMENTAL RESPONSES!

We experiment to get spectacular response. We featured enhanced CEO conference presentations to very small groups in highly readable old Forbes short story style snapshots.
Flaherty Financial News Newsletter
and our sister Flaherty Special Situation Newsletter, which turns out BUY reports, goes out to over 45 million opt-in investors in the U.S., Canada and the U.K. with impressive results. Over 6 million online investors opened an issue featuring CEL-SCI Corp. with over 96,000 clicks. We can magnify and enhance a CEO's presentation to a few investors in a room to millions of new interested investors seeking quality companies. That magnifies your IR enormously.

At 84 Bob still feels a thrill hitting one more pitch out of the ballpark! Please consider making your company or fund one of our CEO Presentation Profiles or a BUY report in an upcoming issue.  

 



August 2017
Flaherty Special Situation Newsletter #39
Will GenOil Inc. (OTCQB:GNOLF) Be The Next Apple?
While battling abusive secret short sellers, David Lifschultz's team at soon to be Curacao -based GenOil Inc. (OTCQB:GNOLF) is successfully making the transition from a developmental to a commercial enterprise. Negotiating 25 contracts with a $110 billion potential. Using its hydro-conversion upgrading desulfurizing technology to turn 900 billion barrels of cheap heavy polluting oil into environmentally friendly fuel-an $18 Trillion to $36 Trillion scope of opportunity! Cleansing the air and water so people everywhere will be healthier. Reducing ship pollution with cleaner maritime bunker fuel. Gearing up to supply 10 million barrels of oil a day to keep China growing.

Click Here Direct Link To Report


June 23, 2017
Flaherty Financial News Newsletter #59
Highlights from the 2017 Marcum Microcap Conference.

Click Here Direct Link To Report


April 2, 2017
Flaherty Financial News Newsletter #58
Flaherty's 36th Annual Favorites of the Famous:
Nine Nifty Stocks for 2017!
May your portfolio get HIGH with the help of our friends.

Click Here Direct Link To Report


March 20, 2017
Flaherty Financial News Newsletter #57
After meeting with the FDA, CEL-SCI (NYSE:CVM) has come up with a plan to address the FDA's issues on CEL-SCI's unique pivotal global Phase 3 head and neck cancer study with its drug treatment Multikine. Patients already enrolled will continue to be followed. Globally 928 patients are enrolled in the study.
Naturally, the future is unknowable and the FDA upon review of CEL-SCI's submission may or may not agree.
Meanwhile, the seemingly endless current hearing on CEL-SCI's $50 million + arbitration suit against its original dismissed clinical research organization now rolled up into a giant continues.
CEL-SCI could lose. But if CEL-SCI settles for a sizable sum or wins its case CEL-SCI's stock value should soar with its expanded ability to execute its immunotherapy dreams.
UNFORTUNATELY FOR CURRENT SHAREHOLDERS CEL-SCI EXECUTED A JUNE 15, 2017 1- for -25 REVERSE STOCK SLPIT DRASTICALLY REDUCING THE HOLDINGS OF OLD SHAREHOLDERS.
We'd stick with CEL-SCI stock until these key question marks on the FDA and the outcome of the $50 million arbitration suit become clarified. CEL-SCI's revolutionary unique pivotal treatment of cancer patients BEFORE not AFTER their immune systems have been devastated by today's standard of deadly chemo and brutal radiation is too important to give up on while there is still hope.
Also in this issue: Ideas from NYC's Bio CEO & Investor conference plus now fired crusading U.S. attorney Preet Bharara announces the Invisible Man Jason Galanis is sentenced to over 11 years in prison.

                                          
Click Here Direct Link To Report


November 20, 2014
Flaherty Special Situation Newsletter #37
BioSig Technologies (OTCQB: BSGM) is revolutionizing the recording of abnormal heartbeat wave signals to improve innovation - starved arrhythmia treatment. Follow Up: Remembering the fairy tale life of one of America's first female financial writers courageous Clare Reckert. The New York Times' first female financial writer and it's first to get a Times' byline, she started with only two initials. Next Clare had to misspell her first name Claire without an (i). A male boss wanted readers to think she was a man. Her efforts for gender parity at The New York Times infuriated the males so much her passing at age 100 didn't receive even a single line of obit in the print edition of the paper. Way to go guys!

Click Here Direct Link To Report


July 23, 2013
Flaherty Financial News Newsletter #37
An update on CORT's unfinished crusade to offset morbid obesity and other deadly side effects afflicting millions of mental patients and stressed veterans relying on our five major antipsychotic drugs.

Click Here Direct Link To The Report


September 11, 2011
Flaherty Financial News Newsletter #28
A tear for the friends we lost in 9-11.
Corcept Therapeutics Inc. (NASDAQ: CORT) tackles the single biggest dilemma in psychiatry. Antipsychotic drugs stabilize mental patients, but with harmful metabolic side effects of morbid obesity, arterial heart disease, stroke and Type 2 diabetes.

Click Direct Link To Report


February 2, 2011
Flaherty Financial News
Newsletter #25
Expose Part 12: The Return of The Invisible Man, Jason Galanis. Mission Accomplished!

Click Direct Link To Report


October 4, 2009
Expose Part 1: "The Invisible  Man  Returns " with the first  actively managed ETF IPOs, plus GEROVA Financial Group (NYSE:GFC) which raises serious  regulatory concerns.
Does past SEC accounting fraud target Jason Galanis have a relationship with Fund.com (FNDM.OB) and its affliate AdvisorShares, initiator  of highly speculative ETF IPOs? "He does." Investors beware! 

Click Direct Link To Report




 

Companies and People with Archive Coverage 2017

August 2017: Flaherty Special Situation Newsletter #39. Will GenOil Inc. (OTCQB:GNOLF) be the next Apple? ARMACO. China Development Bank. Exxon. GenOil environmentalist entrepreneur CEO David Lifschultz and his nephew COO Bruce Abbott. Schlumberger Limited. March 20, 2017. NYC’s 2017 Bio CEO Investor Conference: How short sighted not to keep our national treasure, the Waldorf Astoria Hotel, in U.S. hands. Then it could have continued to protect and even save the life of a sitting president and other potential assassination targets. H.C. Wainwright helps destiny’s tiny tots to finance their struggle to survive as most underwriters focus on bigger fish. Inovio Pharmaceuticals (NASDAQ-INO) shines. Our uninformed young American women are dying in their 20s and 30s from skin cancer from visiting greedy death trap tanning salons.   France’s OSE Immunotherapeutics bargain-priced blockbuster potential. The five major anti-psychotic drugs can help calm disturbed people and veterans with post- traumatic stress short term but trigger morbid obesity and diabetes later. Dr. Joseph Belanoff’s Corcept Therapeutics Inc. (NASDAQ:CORT) continues its progress in developing a commercial product to mitigate the excessive weight gain and some of the other severe metabolic effects. Follow Up: Fired crusading ex-U.S. Attorney for the Southern District of NY  Preet Bharara announced the sentencing of  The Invisible Man Jason Galanis to  prison but our  point is still missed. Today’s micro and small cap stock investors are preyed upon by many active predators engaging in extreme hyping or fear mongering. Their past records and often their past names are no secret to the in-crowd. The only ones kept ignorant are the ones who need to be protected. There needs to be correction to a self-serving system which is failing to protect the vulnerable investing public. Badly needed sunshine would result in more investing by the little guys and gals. Hopefully there would be fewer losses too, especially in questionable companies. Improved disclosure about the records of active past predators would be a good starting point.

April 2, 2017: Flaherty’s 36th Annual Favorites of the Famous: Nine Fine Stocks for 2017! Apple Inc. (NASDAQ:AAPL), Bovie Medical Inc. (NYSE:BVX), Fusion Telecommunications (NASDAQ:FSSN), Hallmark Financial Services, Inc. (NASDAQ: HALL), HDFC Bank of India: (HDB:NYSE), Keysight Technologies, Inc. (NYSE:KEYS), Ontex Group (ONTEX.BR) State Bank of India (BSE:500112), Tredegar Corporation (NYSE:TG). A special thanks to Mario Gabelli and the other Flaherty Favorites of the Famous panelists.

June  2017: Highlights  from the 2017 Marcum Microcap Conference.

Companies and People with Archived Coverage 2016

January, February and March: CEL-SCI Corporation (NYSE:CVM),   Digital Switch Corp. , Ergomed plc (AIM:ERGO) , Keating Wealth Management, Sir John Templeton's stock advice in falling markets.  Wow! Dow 89,000! Sir John's forgotten forecast. April: Flaherty's 35th Annual FAVORITES OF THE FAMOUS: Ten Stocks for tomorrow: AK Transneft, Bovie Medical,  CEL-SCI, Fairfax Financial, Hertz Global Holdings, Myers Industries, National Commerce Corp., Sintex Technologies, Total S.A., Zebra Technologies Corp.

Golden Oldies:  July 13, 2007 - our very first issue of Flaherty Financial News issue:  Pre-Paid Legal Services Inc. is a classic case history on how to defeat abusive short sellers. Bob Flaherty notes that there is nothing wrong with legitimate short selling. However,  abusive short selling where proper share borrowing is not followed or manipulative untrue rumors are spread can lead to the destruction or stunting the growth of many promising ventures. Besides testifying before Congress on the subject,  Flaherty has written or edited over 100 articles on abusive short sellling and been labeled "a crusader" who has been responsible for many reforms. The ShortBuster Day his old friend gadfly  Ray Dirks and Bob ran spotlighted good things about 30 companies that  the main stream press which was close to many abusive shorts neglected to include. Under unfair attack by secret naked short sellers, Pre-Paid Legal Services, SafeCard Services (which had been attacked over 30 consecutive times by Barron's) and totally ignored Cheyenne Software saw their shares zoom. All hell broke loose when Wholesome & Hearty's idealistic founder finally got to tell his side. A sickly youth, he dedicated himself to helping people eat better so they would live longer. The instant his dream went public he was branded a bad guy! There was an avalanche of naked short selling and smears. However his IPO had not yet deposited shares to borrow. That meant the huge short position was mostly naked because there were no shares to legally borrow. Overnight the short position disappeared. That stock rose 540%- more than any other stock on NASDAQ that year. Earlier with Cameron Associates IR founder Rod O'Connor, Bob ran The Short Symposium which led to important reforms. Alas recently new abusive shorts, some secret, have arisen to plague job creating CEOs. We hope regulators will get after the abusers before another 1,000 companies are killed! That is how many companies went under the last  time sleepy regulators didn't do their jobs and act promptly until Congress called them on the carpet.

Nov. 29, 2009 “Our missing angel goes home” – a salute to financial writer Phyllis Feinberg. Also in that issue “Woof, Woof for Mantra Venture Group (MVTG).  
Feb. 2, 2011 “Mission Accomplished!” Big time media finally picked up our reporting. Thanks guys and gals! This issue concluded our 12- issue, 15-month expose which commenced in Oct. 4, 2009 with: “The Invisible Man Returns:  Jason Galanis Reappears.”  Also see Expose part Ten: The Invisible Man doesn’t appear in his active ETF IPO prospectuses.   The expose companies featured Fund.com Inc.  (FNDM.PK) and GEROVA Financial (NYSE:GFC). Both subsequently collapsed. 

Nov. 29, 2014: Remembering the fairy tale life of one of America's first female financial writers courageous Clare Reckert. The New York Times' first female financial writer and it's first to get a Times' byline, Clare had to misspell her first name Claire without an (i). A male boss wanted readers to think she was a man. Her efforts for gender parity at The New York Times infuriated the males so much her passing at age 100 didn't receive even a single line of obit in the print edition of the paper. Way to go guys!

 

Disclaimer- Flaherty Financial News Inc. Where we have conflicts we will disclose them in the relevant newsletter. This is a hybrid journalistic effort where some copy is sponsored and some is not.   

This website and our archived newsletters contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks and uncertainties, and actual circumstances, events or results may differ materially from those projected in such forward-looking statements. We caution readers not to place undue reliance on any forward-looking statements and to supplement our information with specific company SEC filings and their own research. Please be aware that there is risk in every company you buy and the smaller the company, usually the greater the risk. Coverage or other mention of a stock on this website or in a newsletter is neither an offer nor solicitation to buy or sell any securities mentioned. We are not investment dealers or investor advisers registered with the SEC or State Security Authorities. We do not guarantee all the information on this website or in any FFN newsletter is correct, timely or will be updated. Remember some errors are inevitable. Reproduction without written permission from FFN is forbidden. From time to time our staff or Flaherty Financial News Inc. may be a shareholder of any individual company profiled in our newsletters or named on our website. Our editorial policy forbids editorial from buying or selling any stock mentioned in a particular issue until this particular issue is out at least ten business days. In cases where FFN receives compensation for writing a profile or report or for extra distribution we warn that such sponsored coverage becomes similar to an advertorial and does not have the same degree of independence as unpaid unsponsored coverage. As FFN editor I always reserve “Final Copy Responsibility” on what to include and what to leave out of every article and report. We try to be objective, but may fail. We are not security analysts or stockbrokers but financial journalists with all the failings of that profession. You readers must decide the merits of each company yourselves and whether it is suitable for you as an investment. Bob Flaherty, Editor.    

Flaherty Financial News Inc. (FFN) and its newsletters Flaherty Financial News and Flaherty Special Situations are not registered as broker dealers or investment advisers with the U.S. Securities and Exchange Commission or any state securities authority. Our newsletters and their information and content providers make no representations or warranties of any kind in connection with the subject matter, performance or suitability of the information contained in the publications for any purpose and are not liable for the timeliness, accuracy or completeness of the information. The information is provided for general information purposes and is not a substitute for obtaining professional advice from a qualified person or entity familiar with your personal circumstances. Please seek the help and advice of professionals as appropriate regarding the evaluations of any specific security, report, opinion, advice or other content. FFN is not responsible for trades placed by recipients. All opinions expressed, information and date provided are subject to change without notice. FFN, its officers and its employees may have positions in and may from time to time make purchases or sales of the securities discussed or mentioned by FFN. (However, we will avoid front running and the buying or selling of any security about to be discussed until ten business days after our particular report is released to the public.) FFN shall have no liability for any newsletter that is lost, intercepted or not received in a timely manner, or not received at all, for any reason.

Digital Copyright © 2017 Flaherty Financial News Inc. All Rights Reserved